These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

334 related items for PubMed ID: 29634621

  • 1. Management of Stenotrophomonas maltophilia Infections in Critically Ill Children.
    Tokatly Latzer I, Paret G, Rubinstein M, Keller N, Barkai G, Pessach IM.
    Pediatr Infect Dis J; 2018 Oct; 37(10):981-986. PubMed ID: 29634621
    [Abstract] [Full Text] [Related]

  • 2. Treatment Outcomes of Stenotrophomonas maltophilia Bacteremia in Critically Ill Children: A Multicenter Experience.
    Tokatly Latzer I, Nahum E, Cavari Y, Lazar I, Ben-Ari Y, Ben-Shimol S, Ben-Shalom G, Geffen Y, Goldberg L, Rubinstein M, Keller N, Pessach IM, Paret G.
    Pediatr Crit Care Med; 2019 May; 20(5):e231-e239. PubMed ID: 31058792
    [Abstract] [Full Text] [Related]

  • 3. Comparisons between patients with trimethoprim-sulfamethoxazole-susceptible and trimethoprim-sulfamethoxazole-resistant Stenotrophomonas maltophilia monomicrobial bacteremia: A 10-year retrospective study.
    Wang CH, Lin JC, Lin HA, Chang FY, Wang NC, Chiu SK, Lin TY, Yang YS, Kan LP, Yang CH, Chan MC, Yeh KM.
    J Microbiol Immunol Infect; 2016 Jun; 49(3):378-86. PubMed ID: 25081988
    [Abstract] [Full Text] [Related]

  • 4. Fluoroquinolones versus trimethoprim-sulfamethoxazole for the treatment of Stenotrophomonas maltophilia infections: a systematic review and meta-analysis.
    Ko JH, Kang CI, Cornejo-Juárez P, Yeh KM, Wang CH, Cho SY, Gözel MG, Kim SH, Hsueh PR, Sekiya N, Matsumura Y, Lee DG, Cho SY, Shiratori S, Kim YJ, Chung DR, Peck KR.
    Clin Microbiol Infect; 2019 May; 25(5):546-554. PubMed ID: 30448331
    [Abstract] [Full Text] [Related]

  • 5. Monotherapy with minocycline or trimethoprim/sulfamethoxazole for treatment of Stenotrophomonas maltophilia infections.
    Hand E, Davis H, Kim T, Duhon B.
    J Antimicrob Chemother; 2016 Apr; 71(4):1071-5. PubMed ID: 26801080
    [Abstract] [Full Text] [Related]

  • 6. Risk factors for hospital acquisition of trimethoprim-sulfamethoxazole resistant Stenotrophomonas maltophilia in adults: A matched case-control study.
    Wang CH, Lin JC, Chang FY, Yu CM, Lin WS, Yeh KM.
    J Microbiol Immunol Infect; 2017 Oct; 50(5):646-652. PubMed ID: 28688829
    [Abstract] [Full Text] [Related]

  • 7. Molecular epidemiology and risk factors of Stenotrophomonas maltophilia infections in a Chinese teaching hospital.
    Duan Z, Qin J, Liu Y, Li C, Ying C.
    BMC Microbiol; 2020 Sep 29; 20(1):294. PubMed ID: 32993493
    [Abstract] [Full Text] [Related]

  • 8. Stenotrophomonas maltophilia: An emerging opportunistic nosocomial pathogen in a tertiary care hospital in Al Batinah North Governorate, Oman.
    Sannathimmappa MB, Nambiar V, Aravindakshan R, Al-Kasaby NM.
    Sultan Qaboos Univ Med J; 2021 Feb 29; 21(1):e66-e71. PubMed ID: 33777425
    [Abstract] [Full Text] [Related]

  • 9. Stenotrophomonas maltophilia bacteremia in children: risk factors and mortality rate.
    Alsuhaibani M, Aljarbou A, Althawadi S, Alsweed A, Al-Hajjar S.
    Antimicrob Resist Infect Control; 2021 Jan 22; 10(1):19. PubMed ID: 33482916
    [Abstract] [Full Text] [Related]

  • 10. Characteristics of Stenotrophomonas maltophilia infection in children in Sichuan, China, from 2010 to 2017.
    Wang L, Zhou W, Cao Y, Yang C, Liu H, Chen T, Chen L.
    Medicine (Baltimore); 2020 Feb 22; 99(8):e19250. PubMed ID: 32080131
    [Abstract] [Full Text] [Related]

  • 11. Risk factors and molecular mechanisms associated with trimethoprim-sulfamethoxazole resistance in Stenotrophomonas maltophilia in Mexico.
    Herrera-Heredia SA, Pezina-Cantú C, Garza-González E, Bocanegra-Ibarias P, Mendoza-Olazarán S, Morfín-Otero R, Camacho-Ortiz A, Villarreal-Treviño L, Rodríguez-Noriega E, Paláu-Davila L, Maldonado-Garza HJ, Flores-Treviño S.
    J Med Microbiol; 2017 Aug 22; 66(8):1102-1109. PubMed ID: 28771141
    [Abstract] [Full Text] [Related]

  • 12.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 13. Clinical characteristics and risk factors of infections caused by Stenotrophomonas maltophilia in a hospital in northwest China.
    Xun M, Zhang Y, Li BL, Wu M, Zong Y, Yin YM.
    J Infect Dev Ctries; 2014 Aug 13; 8(8):1000-5. PubMed ID: 25116665
    [Abstract] [Full Text] [Related]

  • 14. [Nosocomial Stenotrophomonas maltophilia infections in a university hospital].
    Caylan R, Yilmaz G, Sucu N, Bayraktar O, Aydin K, Kaklikkaya N, Aydin F, Köksal I.
    Mikrobiyol Bul; 2005 Jan 13; 39(1):25-33. PubMed ID: 15900834
    [Abstract] [Full Text] [Related]

  • 15. Stenotrophomonas maltophilia bacteremia in pediatric patients-- a 10-year analysis.
    Wu PS, Lu CY, Chang LY, Hsueh PR, Lee PI, Chen JM, Lee CY, Chan PC, Chang PY, Yang TT, Huang LM.
    J Microbiol Immunol Infect; 2006 Apr 13; 39(2):144-9. PubMed ID: 16604247
    [Abstract] [Full Text] [Related]

  • 16.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 17. Infection and colonization by Stenotrophomonas maltophilia: antimicrobial susceptibility and clinical background of strains isolated at a tertiary care centre in Hungary.
    Juhász E, Krizsán G, Lengyel G, Grósz G, Pongrácz J, Kristóf K.
    Ann Clin Microbiol Antimicrob; 2014 Dec 31; 13():333. PubMed ID: 25551459
    [Abstract] [Full Text] [Related]

  • 18. Independent predictors for mortality in patients with positive Stenotrophomonas maltophilia cultures.
    Kwa AL, Low JG, Lim TP, Leow PC, Kurup A, Tam VH.
    Ann Acad Med Singap; 2008 Oct 31; 37(10):826-30. PubMed ID: 19037515
    [Abstract] [Full Text] [Related]

  • 19.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 20.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 17.